Literature DB >> 18753311

Novel function of STAT1beta in B cells: induction of cell death by a mechanism different from that of STAT1alpha.

Imen Najjar1, Pierre Olivier Schischmanoff, Fanny Baran-Marszak, Pierre-Antoine Deglesne, Ibtissam Youlyouz-Marfak, Mathieu Pampin, Jean Feuillard, Georg W Bornkamm, Mounira K Chelbi-Alix, Remi Fagard.   

Abstract

Alternate splicing of STAT1 produces two isoforms: alpha, known as the active form, and beta, previously shown to act as a dominant-negative factor. Most studies have dealt with STAT1alpha, showing its involvement in cell growth control and cell death. To examine the specific function of either isoform in cell death, a naturally STAT1-deficient human B cell line was transfected to express STAT1alpha or STAT1beta. STAT1alpha, expressed alone, enhanced cell death, potentiated the fludarabine-induced apoptosis, and enhanced the nuclear location, the phosphorylation, and the transcriptional activity of p53. Unexpectedly, STAT1beta, expressed alone, induced cell death through a mechanism that was independent of the nuclear function of p53. Indeed, in STAT1beta-expressing B cells, p53 was strictly cytoplasmic where it formed clusters, and there was no induction of the transcriptional activity of p53. These data reveal a novel role of STAT1beta in programmed cell death, which is independent of p53.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753311     DOI: 10.1189/jlb.0508287

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

Review 1.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

2.  The role of stat1b in zebrafish hematopoiesis.

Authors:  Hao Song; Yi-lin Yan; Tom Titus; Xinjun He; John H Postlethwait
Journal:  Mech Dev       Date:  2011-09-03       Impact factor: 1.882

3.  Potential biological functions of cytochrome P450 reductase-dependent enzymes in small intestine: novel link to expression of major histocompatibility complex class II genes.

Authors:  Jaime D'Agostino; Xinxin Ding; Peng Zhang; Kunzhi Jia; Cheng Fang; Yi Zhu; David C Spink; Qing-Yu Zhang
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

4.  Impaired T-bet-pSTAT1α and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma.

Authors:  Katerina Andreev; Denis Iulian Trufa; Raphaela Siegemund; Ralf Rieker; Arndt Hartmann; Joachim Schmidt; Horia Sirbu; Susetta Finotto
Journal:  Br J Cancer       Date:  2015-09-08       Impact factor: 7.640

5.  Proteoform-Specific Insights into Cellular Proteome Regulation.

Authors:  Emma L Norris; Madeleine J Headlam; Keyur A Dave; David D Smith; Alexander Bukreyev; Toshna Singh; Buddhika A Jayakody; Keith J Chappell; Peter L Collins; Jeffrey J Gorman
Journal:  Mol Cell Proteomics       Date:  2016-07-22       Impact factor: 5.911

6.  Cellular response to alkylating agent MNNG is impaired in STAT1-deficients cells.

Authors:  Laurent Ah-Koon; Denis Lesage; Elodie Lemadre; Inès Souissi; Remi Fagard; Nadine Varin-Blank; Emmanuelle E Fabre; Olivier Schischmanoff
Journal:  J Cell Mol Med       Date:  2016-07-27       Impact factor: 5.310

7.  Physical interaction of STAT1 isoforms with TGF-β receptors leads to functional crosstalk between two signaling pathways in epithelial ovarian cancer.

Authors:  Xiaoling Tian; Wencai Guan; Lingyun Zhang; Wenwen Sun; Daibing Zhou; Qunbo Lin; Weimin Ren; Lubna Nadeem; Guoxiong Xu
Journal:  J Exp Clin Cancer Res       Date:  2018-05-11

8.  STAT1β enhances STAT1 function by protecting STAT1α from degradation in esophageal squamous cell carcinoma.

Authors:  Ying Zhang; Yelong Chen; Hailong Yun; Zhaoyong Liu; Min Su; Raymond Lai
Journal:  Cell Death Dis       Date:  2017-10-05       Impact factor: 8.469

9.  ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.

Authors:  Lushang Jiang; Min Ji Park; Charles J Cho; Kihak Lee; Min Kyo Jung; Chan Gi Pack; Seung-Jae Myung; Suhwan Chang
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

10.  STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity.

Authors:  Katrin Meissl; Natalija Simonović; Lena Amenitsch; Agnieszka Witalisz-Siepracka; Klara Klein; Caroline Lassnig; Ana Puga; Claus Vogl; Andrea Poelzl; Markus Bosmann; Alexander Dohnal; Veronika Sexl; Mathias Müller; Birgit Strobl
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.